Skip to main content
Clinical Trials/NCT02589093
NCT02589093
Completed
Not Applicable

Validation of a Nociception Monitor in Healthy Volunteers

Maisonneuve-Rosemont Hospital0 sites23 target enrollmentOctober 2014
ConditionsPain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
Maisonneuve-Rosemont Hospital
Enrollment
23
Primary Endpoint
ANI index values during increasing intensities of moderately painful electrical stimulation at the forearm level.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Anesthesiology daily practice consists in management of sedation, immobility and analgesia. The monitoring of this last component remains largely based on indirect signs with poor sensitivity and specificity such as heart rate and blood pressure. Accordingly, there is an increased demand for more accurate analgesia monitors. Several parameters have been studied in the recent years such as spectral entropy, skin conductance, pupillometry or heart rate variability (HRV). The HRV is influenced by the balance of sympathetic and parasympathetic tones, and is therefore influenced by pain and analgesia.

MDoloris Medical Systems SAS, located in Lille, France, had developed a monitor called PhysioDoloris (TM) that uses an analysis of the HRV to generate a clinically useable index, the Analgesia-Nociception Index (ANI). The ANI varies from 0 to 100, a lower number indicating less parasympathetic tone. It has been shown in previous studies under general anesthesia to decrease at the moment of surgical incision and pneumoperitoneum inflation and to increase with opioids administration.

The purpose of this study is to show a correlation between the variation of the ANI with pain scores in awake healthy volunteers who are subjected to standardized painful stimuli of increasing intensity. The investigators hypothesize that an increasing pain score will correlate with decreasing ANI values.

Detailed Description

See above

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
December 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Philippe Richebé

M.D.

Maisonneuve-Rosemont Hospital

Eligibility Criteria

Inclusion Criteria

  • Volunteers aged 18-80 years old

Exclusion Criteria

  • Heart disease
  • Neurological disease
  • Allergy to cutaneous electrodes
  • Chronic pain and/or chronic analgesics consumption
  • Medication affecting the autonomic nervous system
  • Inability to understand a numeric rating scale (NRS)

Outcomes

Primary Outcomes

ANI index values during increasing intensities of moderately painful electrical stimulation at the forearm level.

Time Frame: Assessed during the entire cycle of stimulation (approx. 30 min)

The ANI is an index that can vary from 0 (maximum pain) to 100 (no pain) in humans. The primary objective of this study will be to record the ANI values all along the time period of the clinical evaluation, while the subjects are submitted to standardized electrical stimulation going from 0 mA (no stimulation) to a maximum of 25 mA (or less according to the subject tolerance). Each stimulation lasts for 3 minutes. During these 3 minutes the ANI is electronically recorded automatically but the Physiodoloris device. The quantitavive value of the index is then analyzed during each stimulation and for all the stimulations. This will allow to evaluate whether it exists any correlation between the ANI values and the intensity of the electrical stimulation.

Secondary Outcomes

  • Blood pressure correlation with ANI(Assessed during the entire cycle of stimulation (approx. 30 min))
  • ANI correlation with Numerical Rating Scale (NRS) of pain(Assessed during the entire cycle of stimulation (approx. 30 min))
  • Heart rate correlation with ANI(Assessed during the entire cycle of stimulation (approx. 30 min))

Similar Trials